NMS·Healthcare·$2.0B·#156 / 520 in Healthcare
NVCR NovoCure Limited
58SPECULATIVE
CATEGORY BREAKDOWN
GROWTH13
QUALITY63
STABILITY66
VALUATION91
GOVERNANCE69
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+8.3%
13
> 50% strong
Gross Margin
Revenue retained after direct costs
74.5%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
23 months
81
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
72.9%
34
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.9x
91
< 3x strong
Rule of 40
Growth rate plus operating margin
-15
9
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
10.0%
65
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+3.6%
78
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE NVCR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when NVCR's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.